Implementation of A Patient Centered Self-Management Program for Patients With Type 2 Diabetes

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02497170

Enrollment

Registered

2015-07-14

Start date

2015-09-30

Completion date

2016-02-29

Last updated

2016-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes

Brief summary

Translational study based on the American Association of Diabetes Educators 7 behaviors to manage Type 2 diabetes

Detailed description

The Primary Investigator will meet with patients that attend routine visits for Diabetes 2 in the primary care office on a monthly basis to set behavior goals. Behavior goals will be set by patient's choice of 4 out of 7 of the AADE7 recommendations. The goals are health eating, being active, monitoring,taking medications, problem solving, healthy coping, and reducing risk. Once the goal is chosen, the PI and patient will make a plan to address the goals on a monthly basis for four months. There will be pre and post questionnaires that will evaluate diabetes knowledge and self-efficacy. There will also be a pre and post measure of the patient's Hemoglobin A1c which is a measurement that helps determine the extent of glycemic control over a three-month period. The goal of the study is to determine if translation of the AADE7 behavioral goals into the primary care setting will make a difference in diabetes knowledge, self efficacy, and Hemoglobin A1c.

Interventions

BEHAVIORALEducation of goal setting and achievement

Education of American Association of Diabetes Educations 7 behavioral goals and how to achieve them

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

SUPPORTIVE_CARE

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Patients over 18 with Hemoglobin A1c 7 mmol/mol or higher will be included in the study * Patients willing to attend minimum of 4 monthly appointments for diabetes treatment * Patients who give written consent to participate

Exclusion criteria

* Patients below age 18, children are not treated in the facility for type 2 diabetes * Patients who attend less than 4 monthly appointments for diabetes, * Patients who do no give written consent to participate

Design outcomes

Primary

Measure	Time frame	Description
Hemoglobin A1c	4 months	Pre and Post Differences

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026